
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9319387
[patent_doc_number] => 20140051724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS'
[patent_app_type] => utility
[patent_app_number] => 14/063785
[patent_app_country] => US
[patent_app_date] => 2013-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89253
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14063785
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/063785 | Modulators of ATP-binding cassette transporters | Oct 24, 2013 | Issued |
Array
(
[id] => 9307119
[patent_doc_number] => 20140045793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/057599
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58946
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057599
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/057599 | Quinolone compound and pharmaceutical composition | Oct 17, 2013 | Issued |
Array
(
[id] => 11561652
[patent_doc_number] => 09624223
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-18
[patent_title] => 'Morphinan derivative'
[patent_app_type] => utility
[patent_app_number] => 14/772188
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25329
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772188
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/772188 | Morphinan derivative | Oct 14, 2013 | Issued |
Array
(
[id] => 9422445
[patent_doc_number] => 20140107096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt'
[patent_app_type] => utility
[patent_app_number] => 14/053682
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32968
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053682
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053682 | Heteroaryl linked quinolinyl modulators of RORγt | Oct 14, 2013 | Issued |
Array
(
[id] => 10220374
[patent_doc_number] => 20150105366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt'
[patent_app_type] => utility
[patent_app_number] => 14/053797
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 118934
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053797
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053797 | Methylene linked quinolinyl modulators of RORγt | Oct 14, 2013 | Issued |
Array
(
[id] => 9422446
[patent_doc_number] => 20140107097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt'
[patent_app_type] => utility
[patent_app_number] => 14/053707
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77641
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053707
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053707 | Phenyl linked quinolinyl modulators of RORγt | Oct 14, 2013 | Issued |
Array
(
[id] => 10220379
[patent_doc_number] => 20150105372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'SECONDARY ALCOHOL QUINOLINYL MODULATORS OF RORyt'
[patent_app_type] => utility
[patent_app_number] => 14/053906
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34394
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053906
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053906 | Secondary alcohol quinolinyl modulators of RORγt | Oct 14, 2013 | Issued |
Array
(
[id] => 9422443
[patent_doc_number] => 20140107094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt'
[patent_app_type] => utility
[patent_app_number] => 14/053653
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79945
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053653
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053653 | Methylene linked quinolinyl modulators of RORγt | Oct 14, 2013 | Issued |
Array
(
[id] => 13916465
[patent_doc_number] => 10202339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Therapeutic compounds and compositions
[patent_app_type] => utility
[patent_app_number] => 14/435674
[patent_app_country] => US
[patent_app_date] => 2013-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29690
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435674
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435674 | Therapeutic compounds and compositions | Oct 10, 2013 | Issued |
Array
(
[id] => 10399400
[patent_doc_number] => 20150284408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'INHIBITORS OF DNA GYRASE FOR THE TREATMENT OF BACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/434870
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 31478
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434870
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/434870 | Inhibitors of DNA gyrase for the treatment of bacterial infections | Oct 7, 2013 | Issued |
Array
(
[id] => 9597781
[patent_doc_number] => 20140194462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'Alpha-7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/048957
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12202
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048957
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/048957 | α7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof | Oct 7, 2013 | Issued |
Array
(
[id] => 9689282
[patent_doc_number] => RE045108
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2014-09-02
[patent_title] => 'Quinolone compound and pharmaceutical composition'
[patent_app_type] => reissue
[patent_app_number] => 14/038862
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58888
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14038862
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/038862 | Quinolone compound and pharmaceutical composition | Sep 26, 2013 | Issued |
Array
(
[id] => 10331171
[patent_doc_number] => 20150216172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR PLANT DISEASE CONTROL'
[patent_app_type] => utility
[patent_app_number] => 14/430919
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 267845
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14430919
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/430919 | Nitrogen-containing heterocyclic compounds for plant disease control | Sep 24, 2013 | Issued |
Array
(
[id] => 9931113
[patent_doc_number] => 20150079304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'SELECT SCHIFF BASE COMPOUNDS FOR CHEMICAL AGENT DETOXIFICATION'
[patent_app_type] => utility
[patent_app_number] => 14/029952
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4078
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14029952
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/029952 | Select Schiff base compounds for chemical agent detoxification | Sep 17, 2013 | Issued |
Array
(
[id] => 9384584
[patent_doc_number] => 20140088066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'PLATINUM COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/024188
[patent_app_country] => US
[patent_app_date] => 2013-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 31494
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14024188
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/024188 | PLATINUM COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | Sep 10, 2013 | Abandoned |
Array
(
[id] => 10340341
[patent_doc_number] => 20150225346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'METHODS FOR THE PREPARATION OF INDACATEROL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/427568
[patent_app_country] => US
[patent_app_date] => 2013-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7220
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427568
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/427568 | Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof | Sep 8, 2013 | Issued |
Array
(
[id] => 9206224
[patent_doc_number] => 20140005401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'Process for Preparing Quinoline-3-Carboxamide Derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/020941
[patent_app_country] => US
[patent_app_date] => 2013-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4980
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14020941
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/020941 | Process for preparing quinoline-3-carboxamide derivatives | Sep 8, 2013 | Issued |
Array
(
[id] => 10857818
[patent_doc_number] => 08884019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Benzimidazole compound crystal'
[patent_app_type] => utility
[patent_app_number] => 14/020286
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7322
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14020286
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/020286 | Benzimidazole compound crystal | Sep 5, 2013 | Issued |
Array
(
[id] => 9206225
[patent_doc_number] => 20140005402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM'
[patent_app_type] => utility
[patent_app_number] => 14/016399
[patent_app_country] => US
[patent_app_date] => 2013-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4622
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14016399
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/016399 | Crystalline forms of pitavastatin calcium | Sep 2, 2013 | Issued |
Array
(
[id] => 10333107
[patent_doc_number] => 20150218112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS THAT ARE AMELIORATED BY INHIBITION OF HDAC'
[patent_app_type] => utility
[patent_app_number] => 14/419988
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24714
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419988
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419988 | Compounds for use in the treatment of disorders that are ameliorated by inhibition of HDAC | Aug 6, 2013 | Issued |